Zentalis Pharmaceuticals, Inc. Other Comprehensive Income (Loss), Net of Tax
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Other Comprehensive Income (Loss), Net of Tax of $14.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-05-17
- Zentalis Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2021-03-31 was $14.00K.
- Zentalis Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2020-06-30 was -$26.85M.
- Zentalis Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2019-06-30 was -$10.47M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month |
|---|---|---|
| 2021-03-31 | $14.00K 10-Q · filed 2021-05-17 | |
| 2020-06-30 | -$26.85M 10-Q · filed 2020-08-13 | -$42.98M 10-Q · filed 2020-08-13 |
| 2019-06-30 | -$10.47M 10-Q · filed 2020-08-13 | -$18.81M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |